Ep. 118: “Memory B Cell Responses” Featuring Dr. Camila Coelho
Falha ao colocar no Carrinho.
Falha ao adicionar à Lista de Desejos.
Falha ao remover da Lista de Desejos
Falha ao adicionar à Biblioteca
Falha ao seguir podcast
Falha ao parar de seguir podcast
Ep. 118: “Memory B Cell Responses” Featuring Dr. Camila Coelho
-
Narrado por:
-
De:
Sobre este título
Dr. Camila Coelho is a Principal Investigator at the Icahn School of Medicine at Mount Sinai, where her lab studies emerging pathogens. She talks about her lab’s work on mpox and other viruses, her approach to mentorship, and how her MBA education helps her in science. (36:00)
Featured Products and Resources:- Stay up-to-date with the latest in infectious disease news.
- Learn how to isolate highly pure immune cells with a free, on-demand course.
Epigenetic Programming of T Cells – Researchers developed an all-RNA platform for efficient, durable and multiplexed epigenetic programming in primary human T cells. (3:57)
Converting Conventional T Cells to Tregs – Using a combination of cytokines and pharmacological approaches, conventional effector T cells can be converted into functional and stable Tregs. (9:40)
A Host–Pathogen Arms Race – E. coli uses the effector NleL to suppress epithelial extrusion, which aids in bacterial spread. (23:06)
Lactation and Lowered Breast Cancer Risk – Parity induces an accumulation of CD8+ T cells in breast tissue, which reduced tumor growth and increased immune cell infiltration in a mouse model. (28:13)
Image courtesy of Dr. Camila Coelho
Subscribe to our newsletter!Never miss updates about new episodes.
Subscribe